These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 4501679)

  • 1. Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia.
    Jaffe N; Traggis D; Das L; Kim BS; Won H; Hann L; Moloney WC; Dohlwitz A
    Pediatrics; 1972 Apr; 49(4):590-5. PubMed ID: 4501679
    [No Abstract]   [Full Text] [Related]  

  • 2. [L-Asparaginase in the treatment of acute leukemia].
    Mathé G; Amiel JL; Clarysse A; Hayat M; Schwarzenberg L; Schneider M
    Sem Hop; 1970 Apr; 46(17):1135-40. PubMed ID: 4315231
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation in children of the clinical, biological and electroencephalographic side effects of L-asparaginase].
    Olive D; Cartault F; Legras B; Neimann N
    Pediatrie; 1976 Apr; 31(3):259-78. PubMed ID: 1069234
    [No Abstract]   [Full Text] [Related]  

  • 4. L-asparaginase treatment in acute leukemia of childhood.
    Suvatte V; Tuchinda S
    J Med Assoc Thai; 1973 Nov; 56(11):634-44. PubMed ID: 4520350
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to highly purified L-asparaginase during therapy of acute leukemia.
    Hill JM; Loeb E; MacLellan A; Khan A; Roberts J; Shields WF; Hill NO
    Cancer Res; 1969 Aug; 29(8):1574-80. PubMed ID: 4896902
    [No Abstract]   [Full Text] [Related]  

  • 6. Favorable remission induction rate with twice weekly doses of L-asparaginase.
    Jaffe N; Traggis D; Das L; Frauenberger G; Hann HW; Kim BS; Bishop Y
    Cancer Res; 1973 Jan; 33(1):1-4. PubMed ID: 4565907
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia.
    Pratt CB; Simone JV; Zee P; Aur RJ; Johnson WW
    J Pediatr; 1970 Sep; 77(3):474-83. PubMed ID: 5278225
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with L-asparaginase.
    Carbone PP; Haskell CM; Leventhal BG; Block JB; Selawry OS
    Recent Results Cancer Res; 1970; 33():236-43. PubMed ID: 4949163
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preliminary results of the clinical study of a Soviet--produced L-asparaginase from E. coli].
    Kondrat'eva NA; Lorie IlI ; Kruglova GV; Vorob'ev AI; Koshel' IV
    Antibiotiki; 1977 Sep; 22(9):852-7. PubMed ID: 334060
    [No Abstract]   [Full Text] [Related]  

  • 10. L-asparaginase in the treatment of neoplastic diseases in children.
    Jaffe N; Traggis D; Das L; Moloney WC; Hann HW; Kim BS; Nair R
    Cancer Res; 1971 Jul; 31(7):942-9. PubMed ID: 4327086
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of CNS-leukaemia in children with acute leukaemia, induced either with rubidomycin or L-asparaginase.
    de Vaan GA; Marcar JR; Schretlen ED
    Padiatr Padol; 1971; 6(3):230-9. PubMed ID: 5293526
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of acute leukemia with L-asparaginase.
    Loeb E; Hill JM; Hill NO; MacLellan A; Khan A; Alexander TR; Adachi A
    Recent Results Cancer Res; 1970; 33():204-18. PubMed ID: 5292717
    [No Abstract]   [Full Text] [Related]  

  • 13. [L-asparaginase in blast leukemia].
    Georgiev Z; Genova V; Avramova D
    Vutr Boles; 1973; 12(6):25-37. PubMed ID: 4522152
    [No Abstract]   [Full Text] [Related]  

  • 14. [Attempts at treatment of acute leukemia with L-asparaginase].
    Lawkowicz W; Krzemińska-Lawkowiczowa ; Kozlowska J; Polubiec A; Derulska D; Kolakowska-Polubiec K; Litwin J; Rokicka R
    Acta Haematol Pol; 1971; 2(4):305-10. PubMed ID: 5293225
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia.
    Nesbit M; Chard R; Evans A; Karon M; Hammond GD
    Am J Pediatr Hematol Oncol; 1979; 1(1):9-13. PubMed ID: 295576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic complications of the treatment of acute leukemia with L-asparaginase (apropos of 147 cases)].
    Bauters F; Mouton J; Delmas-Marsalet Y; Goudemand M
    Lille Med; 1973 Dec; 18(10):1207-14 passim. PubMed ID: 4212519
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of adult leukemia with L-asparaginase (NSC-109229).
    Onuma T; Rosner F; Levy RN; Cuttner J; Moon JH; Silver RT; Blom J; Falkson G; Burningham R; Glidewell O; Holland JF
    Cancer Chemother Rep; 1971 Jun; 55(3):269-75. PubMed ID: 5315678
    [No Abstract]   [Full Text] [Related]  

  • 18. [L-asparaginase study results (phase II of the clinical trials)].
    Kondrat'eva NA; Kruglova GV; Lorie IuI; Koshel' IV; Kurmashov VI
    Antibiotiki; 1980 Sep; 25(9):686-9. PubMed ID: 6998370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with L-asparaginase of renal and testicular involvement in acute lymphoblastic leukemia in children (author's transl)].
    Armata J; Cyklis R; Legutko L
    Acta Paediatr Belg; 1974; 28(1):49-57. PubMed ID: 4526297
    [No Abstract]   [Full Text] [Related]  

  • 20. [L-asparaginase in the treatment of lymphoblastic leukemia in children].
    Bohlmann HG; Gallmeier WM; Göbel FJ; Stier HW
    Z Kinderheilkd; 1969; 107(2):107-14. PubMed ID: 5262681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.